Senior Director, HEOR & Evidence Strategy

Why Join Intellia?

Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.

We want all of our people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.

### How You Will Achieve More:

### Intellia Therapeutics, a pioneer in gene editing, is preparing for its first launch of one-time gene editing therapies for rare and serious diseases, including hereditary angioedema (HAE) and transthyretin amyloidosis (ATTR). The Senior Director, HEOR & Evidence Strategy will be responsible for setting and executing the integrated evidence strategy to demonstrate value and enable durable access, while also leading Field HEOR to drive payer engagement and inform U.S. coverage and reimbursement decisions.

### This role is the linchpin between global evidence generation and U.S. payer-facing execution—overseeing the Director, HEOR & Evidence Strategy and managing the Field HEOR team. The Senior Director will translate science and economics into compelling value narratives, ensure evidence is embedded into clinical development, and directly support national and large regional payer strategies with robust, credible data.

### **This is a highly strategic, hands-on role tha